NASDAQ:DOX - Amdocs Stock Price, Forecast & News

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs announced a quarterly dividend on Tuesday, November 12th. Investors of record on Tuesday, December 31st will be paid a dividend of $0.285 per share on Friday, January 24th. This represents a $1.14 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Monday, December 30th. View Amdocs' Dividend History.

Amdocs Limited (NASDAQ:DOX) issued its quarterly earnings data on Tuesday, November, 12th. The technology company reported $1.08 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $1.08. The technology company had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a return on equity of 15.98% and a net margin of 11.73%. The company's quarterly revenue was up 2.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.99 earnings per share. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, February 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs issued an update on its first quarter 2020 After-Hours earnings guidance on Monday, November, 25th. The company provided EPS guidance of $1.02-1.08 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.11. The company issued revenue guidance of $$1.015-1.055 billion, compared to the consensus revenue estimate of $$1.04 billion.

3 analysts have issued 1-year target prices for Amdocs' stock. Their forecasts range from $72.00 to $83.00. On average, they anticipate Amdocs' stock price to reach $76.67 in the next year. This suggests a possible upside of 3.0% from the stock's current price. View Analyst Price Targets for Amdocs.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Amdocs.

News articles about DOX stock have trended positive on Friday, according to InfoTrie. InfoTrie rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Amdocs earned a news impact score of 3.0 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the near term. View News Stories for Amdocs.

Amdocs saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 3,170,000 shares, an increase of 6.4% from the December 15th total of 2,980,000 shares. Based on an average daily trading volume, of 660,900 shares, the days-to-cover ratio is currently 4.8 days. Currently, 2.4% of the company's shares are short sold. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Leidos (LDOS), Gartner (IT), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Caci International (CACI), Mantech International (MANT), Teradata (TDC), Virtusa (VRTU), Forrester Research (FORR), Unisys (UIS), The Hackett Group (HCKT) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include Home Depot (hd), Comcast (CMCSA), QUALCOMM (QCOM), Target (TGT), Activision Blizzard (ATVI), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Delta Air Lines (DAL) and Iqvia (IQV).

Amdocs' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include PGGM Investments (0.34%), Boston Trust Walden Corp (0.15%), State of Alaska Department of Revenue (0.06%), Assenagon Asset Management S.A. (0.02%), CenturyLink Investment Management Co (0.01%) and First Hawaiian Bank (0.01%).

DOX stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Boston Trust Walden Corp, Douglass Winthrop Advisors LLC, CenturyLink Investment Management Co, Henry James International Management Inc., First Hawaiian Bank, Wedge Capital Management L L P NC and Arden Trust Co.

DOX stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., State of Alaska Department of Revenue, We Are One Seven LLC, OLD National Bancorp IN, Cerebellum GP LLC, Accurate Investment Solutions Inc. and Raymond James Trust N.A..

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $74.40.

Amdocs has a market capitalization of $10.03 billion and generates $4.09 billion in revenue each year. The technology company earns $479.45 million in net income (profit) each year or $4.07 on an earnings per share basis. Amdocs employs 24,516 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]